Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

Atbasoglu E. C., GÜMÜŞ AKAY G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., ...Daha Fazla

PSYCHOPHARMACOLOGY, cilt.235, sa.4, ss.1029-1039, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 235 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s00213-017-4818-z
  • Dergi Adı: PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1029-1039
  • Anahtar Kelimeler: Dopamine, Genetics, Insulin resistance, Schizophrenia, Schizotypy, Type 2 diabetes mellitus, DRUG-NAIVE PATIENTS, 1ST-EPISODE SCHIZOPHRENIA, NEUROTROPHIC FACTOR, INSULIN-RESISTANCE, GLUCOSE-TOLERANCE, DIABETES-MELLITUS, PSYCHOSIS, ASSOCIATION, HOMEOSTASIS, PREVALENCE
  • Ankara Üniversitesi Adresli: Evet

Özet

Type 2 diabetes (T2D) is more frequent in schizophrenia (Sz) than in the general population. This association is partly accounted for by shared susceptibility genetic variants.